Methamphetamine dependency. Hallucinogen abuse
Conditions
Interventions
Intervention 1: Intervention group: Intervention group: The group will receive Duloxetine treatment in two months.Daily drug intake will be one capsule that will receive a capsule of 20 mg in the firs
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Gender Male Methamphetamine dependence diagnoses accordingly Diagnostic and Statistical Manual of Mental Disorders fifth edition The dominant use of methamphetamine for at least 6 months lack of serious psychiatric disorders
Exclusion criteria
Exclusion criteria: subjects who met opiates dependence non compliance or not willing for continuing the study sever and unbearable drug side effect even after reducing the dose.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression. Timepoint: before intervention- 4 weeks later- 8 weeks later. Method of measurement: Depression Inventory.;Withdrawal symptoms. Timepoint: before intervention- 4 weeks later- 8 weeks later. Method of measurement: Inventory withdrawal symptoms.;Craving. Timepoint: before intervention- 4 weeks later- 8 weeks later. Method of measurement: Craving Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFaezeh Tatari
Kermanshah University of Medical Sciences
Outcome results
None listed